Showing 1 - 10 results of 10 for search 'Chiara M Eandi', query time: 0.04s Refine Results
  1. 1
    Pathogenesis of Vascular Retinal Manifestations in <i>COVID-19</i> Patients: A Review

    Pathogenesis of Vascular Retinal Manifestations in <i>COVID-19</i> Patients: A Review by Elisa D’Alessandro, Aki Kawasaki, Chiara M. Eandi

    Published 2022-10-01
    Get full text
    Article
  2. 2
    Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration

    Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration by Francesca Lazzara, Federica Conti, Chiara Bianca Maria Platania, Chiara M. Eandi, Chiara M. Eandi, Filippo Drago, Filippo Drago, Claudio Bucolo, Claudio Bucolo

    Published 2021-11-01
    Get full text
    Article
  3. 3
    Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice

    Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice by Andrea Montesel, Claudio Bucolo, Ferenc B. Sallo, Chiara M. Eandi

    Published 2021-11-01
    Get full text
    Article
  4. 4
    Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy

    Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy by Camilla Alovisi, Felice Cardillo Piccolino, Marco Nassisi, Chiara M. Eandi

    Published 2020-08-01
    Get full text
    Article
  5. 5
    Case Report: Central Retinal Artery Occlusion in a COVID-19 Patient

    Case Report: Central Retinal Artery Occlusion in a COVID-19 Patient by Andrea Montesel, Claudio Bucolo, Victoria Mouvet, Emmanuelle Moret, Chiara M. Eandi

    Published 2020-12-01
    Get full text
    Article
  6. 6
    Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections

    Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections by Anthony Gigon, Maria Vadalà, Vincenza M. E. Bonfiglio, Michele Reibaldi, Chiara M. Eandi

    Published 2022-08-01
    Get full text
    Article
  7. 7
    Biomarkers in Early Response to Brolucizumab on Pigment Epithelium Detachment Associated with Exudative Age-Related Macular Degeneration

    Biomarkers in Early Response to Brolucizumab on Pigment Epithelium Detachment Associated with Exudative Age-Related Macular Degeneration by Marco Rispoli, Chiara M. Eandi, Luca Di Antonio, Raphael Kilian, Andrea Montesel, Maria C. Savastano

    Published 2021-06-01
    Get full text
    Article
  8. 8
    Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects

    Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects by Justus G. Garweg, Claudine A. Blum, René-Pierre Copt, Chiara M. Eandi, Katja Hatz, Christian F. Prünte, Eleonora Seelig, Gábor M. Somfai

    Published 2023-01-01
    Get full text
    Article
  9. 9
    Drug-Repurposing Strategy for Dimethyl Fumarate

    Drug-Repurposing Strategy for Dimethyl Fumarate by Salvatore Giunta, Agata Grazia D’Amico, Grazia Maugeri, Claudio Bucolo, Giovanni Luca Romano, Settimio Rossi, Chiara M. Eandi, Elisabetta Pricoco, Velia D’Agata

    Published 2023-07-01
    Get full text
    Article
  10. 10
    Subretinal mononuclear phagocytes induce cone segment loss via IL-1β

    Subretinal mononuclear phagocytes induce cone segment loss via IL-1β by Chiara M Eandi, Hugo Charles Messance, Sébastien Augustin, Elisa Dominguez, Sophie Lavalette, Valérie Forster, Shulong Justin Hu, Lourdes Siquieros, Cheryl Mae Craft, José-Alain Sahel, Ramin Tadayoni, Michel Paques, Xavier Guillonneau, Florian Sennlaub

    Published 2016-07-01
    Get full text
    Article

Search Tools: